Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents

Luisa Gilardini, Philip G. McTernan, Andrea Girola, Nancy F. da Silva, Luisella Alberti, Sudhesh Kumar, Cecilia Invitti

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

The aim of this study was to compare the use of several biomarkers to identify obese children and adolescents with increased metabolic risk. One hundred sixty-two Caucasian obese children and adolescents (41% males, 9-18 years old) referred to the Istituto Auxologico Italiano between 2003 and 2004 underwent an oral glucose tolerance test. Circulating levels of adiponectin (AD), plasminogen activator inhibitor 1 (PAI-1), interleukin 18 (IL-18), C-reactive protein (CRP), fibrinogen, uric acid, lipids and insulin were measured. Twenty five percent of obese children had the MS defined using World Health Organization-derived child specific criteria. MS subjects had significantly lower AD (p <0.01) and higher log-PAI-1 (p <0.001), uric acid (p <0.0001), and IL-18 (p <0.001). Subjects with AD levels ≤median value had a significantly increased risk of having the MS (p <0.0001), as did subjects with uric acid and PAI-1 levels greater than the median. There was no increased risk with elevated IL-18, CRP, or fibrinogen. Hypoadiponectinemia was independently associated with the MS risk (p <0.0001). In conclusion in obese children and adolescents AD is the best predictor of MS and thus of higher cardiovascular disease risk.

Original languageEnglish
Pages (from-to)401-407
Number of pages7
JournalAtherosclerosis
Volume189
Issue number2
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Adiponectin
Interleukin-18
Plasminogen Activator Inhibitor 1
Uric Acid
C-Reactive Protein
Fibrinogen
Glucose Tolerance Test
Cardiovascular Diseases
Biomarkers
Insulin
Lipids

Keywords

  • Adiponectin
  • Metabolic syndrome
  • Obese children
  • PAI-1
  • Uric acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. / Gilardini, Luisa; McTernan, Philip G.; Girola, Andrea; da Silva, Nancy F.; Alberti, Luisella; Kumar, Sudhesh; Invitti, Cecilia.

In: Atherosclerosis, Vol. 189, No. 2, 12.2006, p. 401-407.

Research output: Contribution to journalArticle

Gilardini, Luisa ; McTernan, Philip G. ; Girola, Andrea ; da Silva, Nancy F. ; Alberti, Luisella ; Kumar, Sudhesh ; Invitti, Cecilia. / Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. In: Atherosclerosis. 2006 ; Vol. 189, No. 2. pp. 401-407.
@article{b88072050919470bb838a16f0ca0c0c7,
title = "Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents",
abstract = "The aim of this study was to compare the use of several biomarkers to identify obese children and adolescents with increased metabolic risk. One hundred sixty-two Caucasian obese children and adolescents (41{\%} males, 9-18 years old) referred to the Istituto Auxologico Italiano between 2003 and 2004 underwent an oral glucose tolerance test. Circulating levels of adiponectin (AD), plasminogen activator inhibitor 1 (PAI-1), interleukin 18 (IL-18), C-reactive protein (CRP), fibrinogen, uric acid, lipids and insulin were measured. Twenty five percent of obese children had the MS defined using World Health Organization-derived child specific criteria. MS subjects had significantly lower AD (p <0.01) and higher log-PAI-1 (p <0.001), uric acid (p <0.0001), and IL-18 (p <0.001). Subjects with AD levels ≤median value had a significantly increased risk of having the MS (p <0.0001), as did subjects with uric acid and PAI-1 levels greater than the median. There was no increased risk with elevated IL-18, CRP, or fibrinogen. Hypoadiponectinemia was independently associated with the MS risk (p <0.0001). In conclusion in obese children and adolescents AD is the best predictor of MS and thus of higher cardiovascular disease risk.",
keywords = "Adiponectin, Metabolic syndrome, Obese children, PAI-1, Uric acid",
author = "Luisa Gilardini and McTernan, {Philip G.} and Andrea Girola and {da Silva}, {Nancy F.} and Luisella Alberti and Sudhesh Kumar and Cecilia Invitti",
year = "2006",
month = "12",
doi = "10.1016/j.atherosclerosis.2005.12.021",
language = "English",
volume = "189",
pages = "401--407",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents

AU - Gilardini, Luisa

AU - McTernan, Philip G.

AU - Girola, Andrea

AU - da Silva, Nancy F.

AU - Alberti, Luisella

AU - Kumar, Sudhesh

AU - Invitti, Cecilia

PY - 2006/12

Y1 - 2006/12

N2 - The aim of this study was to compare the use of several biomarkers to identify obese children and adolescents with increased metabolic risk. One hundred sixty-two Caucasian obese children and adolescents (41% males, 9-18 years old) referred to the Istituto Auxologico Italiano between 2003 and 2004 underwent an oral glucose tolerance test. Circulating levels of adiponectin (AD), plasminogen activator inhibitor 1 (PAI-1), interleukin 18 (IL-18), C-reactive protein (CRP), fibrinogen, uric acid, lipids and insulin were measured. Twenty five percent of obese children had the MS defined using World Health Organization-derived child specific criteria. MS subjects had significantly lower AD (p <0.01) and higher log-PAI-1 (p <0.001), uric acid (p <0.0001), and IL-18 (p <0.001). Subjects with AD levels ≤median value had a significantly increased risk of having the MS (p <0.0001), as did subjects with uric acid and PAI-1 levels greater than the median. There was no increased risk with elevated IL-18, CRP, or fibrinogen. Hypoadiponectinemia was independently associated with the MS risk (p <0.0001). In conclusion in obese children and adolescents AD is the best predictor of MS and thus of higher cardiovascular disease risk.

AB - The aim of this study was to compare the use of several biomarkers to identify obese children and adolescents with increased metabolic risk. One hundred sixty-two Caucasian obese children and adolescents (41% males, 9-18 years old) referred to the Istituto Auxologico Italiano between 2003 and 2004 underwent an oral glucose tolerance test. Circulating levels of adiponectin (AD), plasminogen activator inhibitor 1 (PAI-1), interleukin 18 (IL-18), C-reactive protein (CRP), fibrinogen, uric acid, lipids and insulin were measured. Twenty five percent of obese children had the MS defined using World Health Organization-derived child specific criteria. MS subjects had significantly lower AD (p <0.01) and higher log-PAI-1 (p <0.001), uric acid (p <0.0001), and IL-18 (p <0.001). Subjects with AD levels ≤median value had a significantly increased risk of having the MS (p <0.0001), as did subjects with uric acid and PAI-1 levels greater than the median. There was no increased risk with elevated IL-18, CRP, or fibrinogen. Hypoadiponectinemia was independently associated with the MS risk (p <0.0001). In conclusion in obese children and adolescents AD is the best predictor of MS and thus of higher cardiovascular disease risk.

KW - Adiponectin

KW - Metabolic syndrome

KW - Obese children

KW - PAI-1

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=33750325774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750325774&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2005.12.021

DO - 10.1016/j.atherosclerosis.2005.12.021

M3 - Article

C2 - 16442116

AN - SCOPUS:33750325774

VL - 189

SP - 401

EP - 407

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -